SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)

Esophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090 cases/year. Two main pathological subtypes exist, squamous cell carcinoma and adenocarcinoma. The main differences between them are localization...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & translational oncology 2016-12, Vol.18 (12), p.1179-1186
Main Authors: Martin-Richard, M., Díaz Beveridge, R., Arrazubi, V., Alsina, M., Galan Guzmán, M., Custodio, A. B., Gómez, C., Muñoz, F. L., Pazo, R., Rivera, F.
Format: Article
Language:English
Subjects:
Adenocarcinoma - diagnosis
Adenocarcinoma - therapy
Carcinoma, Squamous Cell - diagnosis
Carcinoma, Squamous Cell - therapy
Clinical Guides in Oncology
Esophageal Neoplasms - diagnosis
Esophageal Neoplasms - therapy
Humans
Medicine
Medicine & Public Health
Oncology
Practice Guidelines as Topic
Spain
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Esophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090 cases/year. Two main pathological subtypes exist, squamous cell carcinoma and adenocarcinoma. The main differences between them are localization and underlying factors which are the principal cause of the recent incidence changes observed in west countries. Staging techniques and treatment options which combine surgery, chemotherapy and radiotherapy, reflected the high complexity of the EC management. An undeniably multidisciplinary approach is, therefore, required. In this guide, we review the status of current diagnosis and treatment, define evidence and propose recommendations.
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-016-1577-y